Til Danske Kræftforskningsdage 2023 fortæller @Amanda_fbj om sin forskning i cirkulerende tumor DNA Tillykke med at være en af de syv, der modtager prisen ”Exceptional Young Scientist Abstract”! 🎉 #DKD2023 #ctDNA #CancerResearch Dept. of Molecular Medicine

Open Postdoc position at the Medical University of Graz, Austria! 👉There is an open Postdoc position within GUIDE.MRD – an EU project to benchmark and validate available ctDNA assays for MRD detection. #ctDNA #Postdoc

👩‍🎓PhD defence Thur September 21st at 10 AM Amanda Johansen Amanda Frydendahl Boll Johansen will defend her thesis "Blood-based detection of disease in patients with colorectal cancer" at @HealthAarhusUni. Read more here: linkedin.com/posts/moma-auh… #ctDNA #colorectalcancer 📸 AU Photo/Lars Kruse

These days at #ESCP2023 in Vilnius Tenna Vesterman Henriksen and Mai-Britt Worm Ørntoft from the ctDNA Research Center present some exciting research Tenna Vesterman Henriksen about the possibilities of using ctDNA guided decisions - and Mai-Britt Worm Ørntoft about the new RESPONSE project #ctDNA #CancerResearch Dept. of Molecular Medicine

Welcome Jakob Skou Pedersen as a speaker at #cnaps2024, Prof. of Bioinformatics at Dept. of Molecular Medicine. His current research focuses on the development of statistical methods for circulating tumor DNA (#ctDNA) detection and analysis of single-cell data.

Welcome Claus Lindbjerg Andersen, director of the “National Danish Research Centre for circulating tumor DNA guided treatment”, as a speaker at #cnaps2024. His research focuses on translation of basic molecular cancer knowledge into clinical tools.

Yesterday Claus Lindbjerg Andersen and Kåre Gotschalck visited Go'morgen Danmark on TV2 to tell about the promising research in ctDNA🧬 Funding from #KnækCancer has enabled the establishment of the national ctDNA Center and the research🙌 Find the piece at TV2 play #ctDNA #gotv2dk

Thank you for two inspiring days at the Annual Meeting 2023 last week! Focus at the meeting: 👉Updates on ctDNA research DK 👉The way from trial to clinical implementation of ctDNA 👉ctDNA RECIST as a tool for monitoring therapy response 👉Collaboration and networking across DK

New paper out in Annals of Oncology 🧬📢 Great work by Tenna Vesterman Henriksen and the research team of Claus Lindbjerg Andersen 🙌 👉 Read the article here: annalsofoncology.org/article/S0923-… #ctDNA #CancerResearch

1000 tak @ClausLindberg fra Dept. of Molecular Medicine for endnu engang at stille op lære fra dig af din store viden om #ctDNA 🙏🏼 det var en fantastisk god og meget pædagogisk gennemgang - spot-on til #ungekræftlæger til vores jule-webinar her til aften 🎄

BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt. Blodprøver kan være et redskab til prioritering af operationskapacitet på kræftområdet. linkedin.com/posts/aarhus-u… 📷Jens Løgstrup

We wish you all a Merry Christmas and Happy New Year! 🎄 Thank you for the amazing collaboration! We look forward to more national research in ctDNA guided cancer treatment in 2024 #ctDNA #CancerResearch Claus Lindbjerg Andersen | Lars Dyrskjøt DCCC | Kræftens Bekæmpelse

Gratis AUH-foredrag - også online - om strålebehandling og kræft-DNA i blodet ved Klaus Seiersen fra DCPT proton therapy og Claus Lindbjerg Andersen fra Dept. of Molecular Medicine den 27. februar kl 16 fagperson.auh.dk/om-os/oplev-au… ctDNA_DK

In these days CNAPS 2024 is taking place in Graz, Austria. The center is represented with both participants and presentations about circulating tumor DNA 🩸🧬 Thank you for organizing this exciting conference, #CNAPS2024 #ctDNA #CancerResearch

Så er der snart frist, hvis du vil have del i DCCC’s pulje! Send din ansøgning senest d. 22. april kl. 08 – læs mere: dccc.dk/sog-stotte/ #samarbejdeomkræft #dkforsk

Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by Jørgen Bjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples. Key findings: •CtDNA-negative